Computerized System Assurance (CSA) is a modern approach to validating automated systems, particularly in the life sciences industry. It emphasizes a risk-based methodology, focusing on product quality and patient safety, rather than the traditional, more burdensome Computer System Validation (CSV) approach [1], [2]. This article delves into the intricacies of CSA, highlighting the dos and don\u2019ts of validating complex computerized systems.<\/p>\n\n\n\n
CSA is designed to streamline the validation process by applying critical thinking and a risk-based approach. It aims to ensure that computerized systems are reliable, safe, and effective, reducing unnecessary documentation and testing efforts [3]. The key principles of CSA include:<\/p>\n\n\n\n
1- Risk-Based Approach<\/strong>: Prioritizing validation activities based on the risk to patient safety, product quality, and data integrity.<\/p>\n\n\n\n 2- Critical Thinking<\/strong>: Encouraging a thoughtful and analytical approach to validation, focusing on what truly matters.<\/p>\n\n\n\n 3- Lifecycle Approach<\/strong>: Considering the system’s entire lifecycle, from development to decommissioning.<\/p>\n\n\n\n 4- Efficiency and Effectiveness<\/strong>: Reducing the validation burden by focusing on high-risk areas and leveraging existing data and testing.<\/p>\n\n\n\n The following table outlines the dos and don\u2019ts of computerized system validation, with explanations based on system complexity:<\/p>\n\n\n\n Table 1: DOs and DON\u2019Ts in Computerized System Validation<\/strong><\/p>\n\n\n\n Applying Computerized System Assurance (CSA) to legacy systems can be challenging but highly beneficial. Here are some steps to help you integrate CSA principles into your existing systems:<\/p>\n\n\n\n 1- Conduct a Risk Assessment<\/strong>:<\/p>\n\n\n\n 2- Leverage Existing Documentation<\/strong>:<\/p>\n\n\n\n 3- Implement Risk-Based Testing<\/strong>:<\/p>\n\n\n\n 4- Enhance Documentation Practices<\/strong>:<\/p>\n\n\n\n 5- Engage Cross-Functional Teams<\/strong>:<\/p>\n\n\n\n Continuous Monitoring and Improvement<\/strong>:<\/p>\n\n\n\n Table 2: Example of Applying CSA to Legacy Systems<\/strong><\/p>\n\n\n\n Adopting the CSA approach for computerized system validation can significantly enhance the efficiency and effectiveness of the validation process. It requires focusing on risk, leveraging critical thinking, and applying a lifecycle approach. Then, organizations can ensure their systems are safe, reliable, and compliant with regulatory requirements [4]. By following the above-described steps, you can effectively apply CSA principles to your legacy systems, ensuring they remain compliant, reliable, and efficient. <\/p>\n\n\n\n 1- Qualio – Complete guide to computer system validation, https:\/\/www.qualio.com\/blog\/complete-guide-to-computer-system-validation, Accessed on AUG 29, 2024<\/p>\n\n\n\n 2- FDA – Computer Software Assurance for Production and Quality System Software, https:\/\/www.fda.gov\/media\/161521\/download, Accessed on AUG 29, 2024<\/p>\n\n\n\n 3- eLeaP – Computer System Assurance: FDA Guidance and Case for Quality, https:\/\/www.eleapsoftware.com\/fda-transition-to-computer-system-assurance-the-new-csv\/, Accessed on AUG 29, 2024<\/p>\n\n\n\n 4- ValGenesis – Your Guide to Computer Software Assurance, https:\/\/www.valgenesis.com\/blog\/your-guide-to-computer-software-assurance, Accessed on on AUG 29, 2024<\/p>\n\n\n\n 5- Microsoft Copilot in Bing, AI Companion, https:\/\/www.bing.com\/chat?form=NTPCHB, Accessed on AUg 23, 2024<\/p>\n\n\n\n About the author<\/strong>: Kossi Molley, PMP., LSSBB., Chemist<\/a><\/p>\n\n\n\nB- DOs and DON\u2019Ts in Computerized System Validation<\/h2>\n\n\n\n
Complexity Level<\/strong><\/th> DOs<\/strong><\/th> DON\u2019Ts<\/strong><\/th> Explanation<\/strong><\/th><\/tr><\/thead> Low Complexity<\/strong><\/td> – DO<\/strong> use automated tools for routine testing.
– DO<\/strong> leverage vendor documentation.<\/td>– DON\u2019T<\/strong> over-document low-risk systems.
– DON\u2019T<\/strong> ignore vendor-supplied validation evidence.<\/td>Low-complexity systems typically have well-defined functions and lower risk, allowing for streamlined validation processes.<\/td><\/tr> Medium Complexity<\/strong><\/td> – DO<\/strong> perform risk assessments to identify critical areas.
– DO<\/strong> use a combination of automated and manual testing.<\/td>– DON\u2019T<\/strong> rely solely on vendor documentation.
– DON\u2019T<\/strong> skip periodic reviews and updates.<\/td>Medium complexity systems require a balanced approach, combining vendor documentation with additional testing and periodic reviews to ensure ongoing compliance.<\/td><\/tr> High Complexity<\/strong><\/td> – DO<\/strong> implement comprehensive risk management plans.
– DO<\/strong> involve cross-functional teams in validation.<\/td>– DON\u2019T<\/strong> underestimate the need for thorough documentation.
– DON\u2019T<\/strong> neglect continuous monitoring and improvement.<\/td>High-complexity systems pose significant risks and require detailed validation plans, extensive documentation, and continuous monitoring to ensure they remain compliant and effective.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n C- Steps to Apply CSA to Legacy Systems<\/h2>\n\n\n\n
\n
\n
\n
\n
\n
\n
D. Example of Applying CSA to Legacy Systems<\/h3>\n\n\n\n
Step<\/strong><\/th> Action<\/strong><\/th> Explanation<\/strong><\/th><\/tr><\/thead> Risk Assessment<\/strong><\/td> Identify critical legacy systems and evaluate risks.<\/td> Focus on systems that impact product quality and patient safety.<\/td><\/tr> Leverage Documentation<\/strong><\/td> Review and utilize existing validation and vendor documentation.<\/td> Identify gaps and use available evidence to support validation.<\/td><\/tr> Risk-Based Testing<\/strong><\/td> Prioritize testing for high-risk areas and use automated tools.<\/td> Streamline validation by focusing on critical components.<\/td><\/tr> Enhance Documentation<\/strong><\/td> Document changes and maintain traceability.<\/td> Ensure thorough records of all validation activities.<\/td><\/tr> Engage Teams<\/strong><\/td> Involve cross-functional teams in the validation process.<\/td> Foster collaboration and address issues effectively.<\/td><\/tr> Continuous Monitoring<\/strong><\/td> Implement monitoring tools and conduct regular reviews.<\/td> Ensure ongoing compliance and system effectiveness.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n E. Conclusion<\/h2>\n\n\n\n
References <\/h2>\n\n\n\n